A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Trial details
- Registry ID
- NCT07533942
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ONC206
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaNCT07533942 | Jazz Pharmaceuticals | Phase 2 | Recruiting | 2028-10-25Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |